chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had tested positive for COVID on January 4, 2022. While having Covid-19 I've had the normal symptoms.
10 days post vax,pt dev rash at site of inject,area also tender.Pt also had an area of welts(erythema multiforme) worsened and was admitted into hospital for IV steroids and antibiotics. At discharge, diffuse rash purple due to vasiculitis.
Allergic (Urticaria) reaction. Treatment 1 - Benadryl elixir 12.5mg by mouth.  2 - Decadron 4mg
Narrative: 84 yo male patient with the following problem list: PROBLEM LAST MOD PROVIDER Chronic congestive heart failure (SCT 88805009) 11/29/2021 (ICD-10-CM I50.22) Abnormal weight loss (SCT 267024001) (ICD-10-CM 11/19/2021 R63.4) Chronic sinusitis (SCT 40055000) (ICD-10-CM 11/19/2021 J32.9) Chronic obstructive lung disease (SCT 13645005) 11/19/2021 (ICD-10-CM J44.9) Urinary incontinence (SCT 165232002) (ICD-10-CM 11/19/2021 R32.) Chronic cough (SCT 68154008) (ICD-10-CM R05.3) 11/19/2021 Restlessness behavior (SCT 162221009) (ICD-10-CM 06/30/2021 R45.1) History of alcohol abuse (SCT 371434005) 01/03/2020 (ICD-10-CM F10.21) History of partial gastrectomy (SCT 01/03/2020 107701000119101) (ICD-10-CM Z98.890) Seen by palliative care service (SCT 441874000) 09/21/2021 (ICD-10-CM Z51.5), Onset 12/00/2019 Cerebral infarction (SCT 432504007) (ICD-10-CM 09/06/2019 I63.9) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.2) 11/08/2018 Benign essential hypertension (SCT 1201005) 11/08/2018 (ICD-10-CM I10.) Vascular dementia without behavioral disturbance 11/29/2021 (SCT 16276361000119109) (ICD-10-CM F01.50) Probable Major Vascular Neurocognitive Disorder Gastroesophageal reflux disease (SCT 235595009) 11/08/2018 (ICD-10-CM K21.9) Benign prostatic hyperplasia (SCT 266569009) 11/08/2018 (ICD-10-CM N40.0) Patient passed while in Hospice care on 12/15/21 @ 1145 AM. Pt had received covid vaccines on 1/14/21 & 2/11/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
This spontaneous report was received from a 70 years old female consumer reporting on herself with allergy to penicillin, guanfacine, codeine, morphine, BENADRYL, naproxen, DARVOCET, ciprofloxacin, promethazine, hydrocodone, tramadol allergy and drug allergy. The patient's medical history included chickenpox and shingles (in the 1990's). The patient was vaccinated with a dose of ZOSTAVAX (lot #, dose and route not reported) on 01-JUL-2008. No other co-suspects were reported. No concomitant medications were reported. The consumer reported that on 01-NOV-2012, the patient began experiencing nerve pain in an unspecified area of her body. On or around 14-NOV-2012, the patient developed a rash on an unspecified area of her body. She saw the physician on 20-NOV-2012, who diagnosed the rash as shingles. The physician prescribed the patient ZOVIRAX 400 mg 5 times daily to treat the shingles. No lab diagnostic tests were performed. At the time of the report the outcome of shingles was reported as not recovered. The relatedness for the event was not provided for ZOSTAVAX. Additional information has been requested.
5/19/99 9PM 1 episode diarrhea;5/20/99 4:00 HR 1 episode vomiting;no elevated temp;
Pt c/o dizziness 2 mins after hep B and Tb given. Pt had nothing to eat or drink prior to imms.
This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. Information regarding patient's concurrent conditions, pertinent medical history or drug reactions was not provided. On 03-FEB-2017, the patient was vaccinated with an expired dose of VAQTA 0.5 ml, Intramuscularly, which had a lot # L048222 and expiry date on 19-DEC-2016 (anatomical location was not mentioned) for prophylaxis. However, at the reporting time no adverse effects were reported. Additional information has been requested.
PATIENT HAD ACUTE ONSET PROSTRATION STRIDER, CHEMOSIS AND ALTERED MENTAL STATUS. ADMINISTERED EPIPEN, AND THEN ORAL BENADRYL, PREDNISONE
Pt recvd vax & exp bleeding @ site, swelling & induration; ice applied 20-40 mins; exp 24 hrs of idarrhea;
A report has been received from a Pharmacist concerning a 45 year old, female subject, height: 53 inches, weight: 180.0 pounds, who had been receiving nasal FLUMIST Quadrivalent 2in/2ml every year. FLUMIST Quadrivalent started on 26-NOV-2014. The patient experienced flu like symptoms on dental technician exposed to fumes/gas of approximately 200 doses of FLUMIST being autoclaved for destruction which started on 28-NOV-2014. FLUMIST Quadrivalent was discontinued on 28-NOV-2014. The patient recovered from the event of flu like symptoms on dental technician exposed to fumes/gas of approximately 203 does of FLUMIST being autoclaved for destruction on 28-NOV-2014. The report was considered to be non-serious.
Swollen lymph node in left armpit and pain Fever, chills, muscle aches, fatigue Dizziness and feeling disconnected  I have been on bed rest and Advil for the last 4 days and am still sick
Early Sunday morning I developed significant chills (literally my teeth were chattering) that went on for hours. I did not take my temp at this time. I took some Advil, put addition coverings on and was able to fall asleep. In the morning, I was very achy, had a bad headache and had a temp of 101. (The highest it got was 102 over the next 36-40 hours). My temperature didn't break until Monday afternoon. But then it returned early in the evening to 101.2. I was very weak, tired, no appetite, headache, and feverish until this morning which is Tuesday at 10:00. I feel better this morning, not achy, just wiped out. I had the virus last March and this few days was worse than when I had it.
Patient reported heart racing and sweating.  Then patient developed itching and hives.  Patient was treated in our ER for symptoms with Methylprednisolone 125 mg IVP, Famotidine 40 mg IVP, Diphenhydramine 50 mg IVP, and epinephrine 0.3 mg subcutaneously.  Patient was sent home with a Medrol Dosepack.
Following the vaccine a blood clot formed in my brain.  I suffered a stroke and a seizure.  An emergency thrombectomy was attempted.  I was in a coma for two weeks, followed by months of PT and OT.  I still suffer from seizures.  9/26/08 Reviewed hospital medical records of 8/9-8/29/2007. FINAL DX: superior sagittal sinus thrombosis; bilateral frontal hemorrhage. Records reveal patient experienced progressively worsening HA x 3 days w/visual changes, tinnitus & nausea.  Tx w/Benadryl, steroids & ASA at outlying hospital.  Developed right side facial & limb weakness, had generalized tonic-clonic seizure & was intubated prior to transfer. Had tongue laceration. Tx w/anticoagulant drip, antiseizure meds, antibiotics & steroids.  Interventional radiology debulked clot but unable to reestablish blood flow. Developed steroid induced diabetes & tx w/insulin.  Neuro & clinical exam slowly improved.  Extubated 8/22 & on tube feedings until 8/28 when transitioned to PO.  Transferred to inpatient rehab.
Extremely sore arm, headache that went from dull to bad the morning after the shot. The joint and body aches
Itchy red rash developed on my face, neck, chest and stomach approximately 32 hours post vaccination. I had the same response after the first and second doses.
10-29-14 Right upper arm: inflamed, raised area around where vaccinated 3 inch height 4 1/2 inch diameter. Hard core 1 inch in size. Hot to touch, red. 10/30/14: about 1/3 of original size. Pt says no pain and no impediment to movement at all.
doses of improperly stored MMR II were administered to 9 patients on  unspecified dates; No additional adverse symptoms reported; This spontaneous report has been received from an officer manager, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and, previous drugs reactions or allergies were not provided by the reporter.  On an unknown date, the patient was vaccinated with an improperly stored (product storage error) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), (therapy type: rha), lot number S006051, and expiration date 27-FEB-2021 for prophylaxis. Details about strength, dose, dose number, route of administration, and anatomical location were not provided. It was unknown if the sterile diluent (DILUENT MRK) (lot number and expiration date were unknown by the reporter) used for reconstitution of the vaccine, was stored at proper temperature.  The highest temperature was above 47 degree Fahrenheit (°F) (53 Fahrenheit ), for a timeframe of 17 hours, with no previous temperature excursion. The call was due to the Digital Data Logger.  No additional adverse symptoms were reported.  This case is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2001USA005521: US-009507513-2001USA005522: US-009507513-2001USA005523: US-009507513-2001USA005524: US-009507513-2001USA005516: US-009507513-2001USA005519: US-009507513-2001USA005518: US-009507513-2001USA005520:
Presented via EMS w/ dyspnea, hypoxia, cough, diarrhea, fever. Covid +/pneumonia, tx w/ dexamethasone,
A non-serious report of administration of expired FLUMIST was received from an Air Force non-commissioned officer concerning a 22-year-old male. The patient's medical history and concomitant medications were not reported. On 06-Oct-2008, the patient was given FLUMIST via nasal administration by an immunization health technician. The vaccine was found to be expired when a nurse in the same clinic noted that the lot# of the administered FLUMIST (expiration date 24-Mar-2008) was different from the lot# of the other supply of FLUMIST with expiration date of 25-Dec-2008. The expired lot of FLUMIST was given to 17 adult individuals including this patient. The reporter stated that prior to being informed by the immunization clinic, the expired lot of FLUMIST was already suspended for use by their office and that suspended lot is collected by a contracted company for disposal. There was no adverse event associated with this medication error at the time of the report, nor upon follow-up of the event; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 09-Apr-2009 and incorporated into the narrative: added Product Complaint Investigation results.
28JAN approx 950AM (5-10min) p/vax pt put head down didn't feel well, cold & pale, diaphoretic-orientated TPP, refused to open eyes/20 mins; pulse 80 reg drank sprite & cold cloth on face MD called to ER; poss syncopy;
shakes; headache; feel real bad for about 8 hours; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TREMOR (non-serious), outcome "unknown", described as "shakes"; HEADACHE (non-serious), outcome "unknown"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "feel real bad for about 8 hours".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A mother reported that her son received his second doses of Prevnar, DTP (manufacture unknown), IPOl (Aventis) , and Hib (manufacture unknown) vaccines in March, 2002 at 4 months of age and developed an ear infection in both ears in April 2002 at 5 months of age He was treated with Zithromax (azithromycin); however , the infection reportedly did not resolve. He was then treated with rocephin (ceftriaxone) injection and recovered. No further information was available at the date of this report. This patient also developed an ear infection in both ears following receipt of his first and third doses of Prevnar, DTP, IPOl and Hib vaccines. See MCN HQ272214JUN2002 and MCN HQ2846817JUN 2002
Information has been received from a  licensed visiting nurse concerning a patient who on an unspecified date was vaccinated with the second dose of VARIVAX (Merck) (lot not reported) and may possible have developed chicken pox. The patient was sent home from school, the nurse also stated that a parent from school called the office and reported that there were five other cases of chickenpox. This is one report from several from the same source. Additional information has been requested.
Received call on 01/13/2014 from niece inquiring as to vaccines received by client. Stated client was hospitalized after she became disoriented on 01/08/2014 and developed seizures which have been uncontrollable. Remains in ICU (stable).
Patient received vaccine while seated and continued to sit while waiting for 15 minute observation period post-injection. After about 5 minutes, patient lost consciousness while seated. She regained consciousness on her own after about 30 seconds. She remained in her chair, no injuries noted. 911 was notified and EMT arrived on scene to take blood pressure, blood sugar, and do a 4 lead EKG. Per EMT everything was within normal limits and she did not have to be transported to another facility. Patient then left with her mother. No medications had to be administered and CPR/AED were not required.
Delayed localized hypersensitivity reaction in left arm at site of the vaccination. This also occurred after first Moderna COVID-19 vaccination and now again after SECOND Moderna COVID-19 vaccination. In just 8 hours following the second vaccination, a lump appeared under the skin at vaccination site on left arm. The area was swollen, hot to the touch, and there was a red rash on the skin above the lump. The lump under the skin was treated with Zyrtec 10 mg- once per day; and Aleve 220 mg- twice per day. An ice pack was applied as needed. Cortizone cream was applied topically to the rash as needed. Additionally, lymph nodes under the left arm and along the left breast were swollen and sore. Within four days (taking medications listed above) these symptoms had lessen significantly. Within seven days the lump and rash at the injection site were gone and lymph nodes were no longer swollen or sore. Medication treatment was terminated.
crankiness,uncontrollable crying,eyes rolling back in head,eyes dilating in bright sunlight,startle movements @ every noise, becoming more/more lethargic,not tracking toys,dec in smiles;annual f/u: tongue thrust;low oral-facial muscle tone;
chills for 4 days; headache for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills for 4 days) and HEADACHE (headache for 4 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 006M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu vaccine. Past adverse reactions to the above products included No adverse event with Flu vaccine.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced CHILLS (chills for 4 days) and HEADACHE (headache for 4 days). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency; IBUPROFEN for Adverse event, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PARACETAMOL (NYQUIL COLD & FLU) for Adverse event, at an unspecified dose and frequency. On 19-Mar-2021, CHILLS (chills for 4 days) and HEADACHE (headache for 4 days) had resolved.            No concomitant medications were reported.  Treatment medication also included decongestant.   This case was linked to MOD-2021-400107 (Patient Link).; Sender's Comments: No CC is required as all reported events are non-serious.
pain; This case was reported by a physician via call center representative and described the occurrence of pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 5 months after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was resolved with sequelae.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were reported as follows: MD states he experienced slight pain following Shingrix administration in May 2019 that lasted for a day or so then subsided.  He states it was probably administered in his left arm and believes it was adminstered IM. The reporter consented to follow up.  No lot number or expiration date available.  This case has been linked with US2019165617, reported by same reporter.
Several minutes after receiving the vaccinations the patient felt very nauseous and faint. Sat down then laid down on the ground with legs bent at the knee. Reported feeling tingling sensation throughout arms and hands. Tingling feeling went away after 5-10 minutes. I sat with the patient for approximately 10 minutes, monitored his respiration rate, checked his pulse and O2 sat, and blood pressure. All values were within normal range for the patient. Patient remained alert aware and oriented the entire time, never lost conscious.
temp of 102. R arm sore-believes vaccine was administered too high. Should be 2-3 fingers down from shoulder. This vaccine was 1 finger down.
After Flu vaccination, severe peripheral neuropathy developed within two days, requiring patient to be hospitalized for pain control, life monitoring, symptoms continue to progress, suspected CIDP or Guillain-Barre syndrome acquired.
Patient passed out about 5-10 min after vaccine was given. Patient came to and was evaluated by Provider.
11 year old patient presented with her mother. Hard copy paperwork and Color data base systemn used for medical record keeping both showed the appointment was for the Pfizer Vaccine.  A pediatric dose of Pfizer was already drawn up and ready to give. The mother stated to the nurse that she wanted her daughter to have Moderna. Mother has previously had Moderna and felt more comfortable with her child having the same series of vaccine as her. The Nurse then drew up a dose of Moderna lot number 025L21B .5 and administered it to patient.  The patient was monitored for 30 minutes and showed no signs of a reaction
Patient  received a Booster dose of 0.5ml at a pharmacy; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Patient  received a Booster dose of 0.5ml at a pharmacy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Patient  received a Booster dose of 0.5ml at a pharmacy). At the time of the report, ACCIDENTAL OVERDOSE (Patient  received a Booster dose of 0.5ml at a pharmacy) outcome was unknown.            Concomitant medications details were not reported by the reporter. Patient received the primary series of the Moderna Covid-19 Vaccine. Treatment details was not reported by the reporter.   This case was linked to MOD-2022-513834 (Patient Link).
I have strong immune response. The next day I had a softball size lump on my shoulder. I caught the Omicron variant after the 2nd dose of the Moderna vaccine. The doctor said to give it time to go away. My doctor thought that I was having a immune response due to being fully vaccinated and having COVID-19. She indicated that my immune system was hyperactive. I was prescribed 50mg Hydroxyzine to take every 6 hours. All of my symptoms have subsided and I have completely recovered.
Flu Vaccine administered too high and too posterior resulting in almost immediate onset of persistent pain, weakness, loss of range of motion x 6 weeks. Some indication of possible neuro and/or vascular involvement: mottling, increased cap refill, cold to touch, numbness in fingers #4 and 5. Evaluated by workplace Nurse Practitioner, currently on leave for Worker's Comp. Unable to take NSAIDs due to history of gastric ulcers. Receiving Physical Therapy since 3/6/2018, 2 x week. Consult and being followed by Ortho since 3/21/2018. As of 4/5/2018, shoulder range of motion has improved with no improvement in pain, pain much worse when laying down, pain at rest has increased labs from 3/22/2018 show increased inflammatory markers and very slight increase in WBCs. Plan at this point is to administer cortisone injection into shoulder joint once labs reflect no active infection, if that is not possible, aspiration of fluid from Bursa under fluoro, if no improvement, surgical debridement of left shoulder Bursa.
On 6/18/2021, started to feel brain fog, nausea, lethargy, and fatigue.  On 6/19/2021, started to progress to cold sweats, muscle soreness in his legs.  Went to Urgent Care, thought it was viral once Covid Rapid test came back negative, prescribed Azithromycin.  On 6/20, the above symptoms continued.  In the evening of 6/20, started with joint pain, bone pain.  Progressed from legs to upper back, to the neck.  Pain has worsened.  Tylenol, Ibuprofen, heat, ice, and massage not helping, symptoms remain to the point can not walk without excruciating pain.  Not able to sleep because the pain is constant.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066F21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that vaccine administered to total 24 patients including 15 males and 9 females. No concomitant medications was reported. HCP reported administrations were mostly for booster shots. No treatment medications was reported. No side effects was reported.